Pandaroside B

(2S,3S,4S,5R,6R)-6-[[(3S,5S,8R,9S,10S,13S,14R)-17-[(2R,5R)-5-ethyl-6-methyl-4-oxoheptan-2-yl]-16-hydroxy-10,13-dimethyl-15-oxo-1,2,3,4,5,6,7,8,9,11,12,14-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

NRXAOKUYKSNYAW-HDRDTERVSA-N CHEBI:187613 0 Reactome links 2 studies

2 Observed studies

2 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: NRXAOKUYKSNYAW-HDRDTERVSA-N
InChI Key: NRXAOKUYKSNYAW-HDRDTERVSA-N
IUPAC name: (2S,3S,4S,5R,6R)-6-[[(3S,5S,8R,9S,10S,13S,14R)-17-[(2R,5R)-5-ethyl-6-methyl-4-oxoheptan-2-yl]-16-hydroxy-10,13-dimethyl-15-oxo-1,2,3,4,5,6,7,8,9,11,12,14-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
Preferred name: Pandaroside B
INN name: —
Synonym: —
ChEBI: CHEBI:187613

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles